Point72 Hong Kong’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-126
| Closed | -$2.58K | – | 540 |
|
2024
Q3 | $2.58K | Buy |
+126
| New | +$2.58K | ﹤0.01% | 425 |
|
2022
Q4 | – | Sell |
-1,097
| Closed | -$61K | – | 840 |
|
2022
Q3 | $61K | Buy |
+1,097
| New | +$61K | ﹤0.01% | 856 |
|
2022
Q2 | – | Sell |
-2,270
| Closed | -$165K | – | 1784 |
|
2022
Q1 | $165K | Buy |
+2,270
| New | +$165K | 0.01% | 535 |
|
2021
Q4 | – | Sell |
-866
| Closed | -$116K | – | 1659 |
|
2021
Q3 | $116K | Buy |
+866
| New | +$116K | ﹤0.01% | 705 |
|
2020
Q4 | – | Sell |
-4,371
| Closed | -$87K | – | 1513 |
|
2020
Q3 | $87K | Buy |
+4,371
| New | +$87K | 0.01% | 582 |
|
2019
Q2 | – | Sell |
-270
| Closed | -$5K | – | 1317 |
|
2019
Q1 | $5K | Buy |
270
+193
| +251% | +$3.57K | ﹤0.01% | 817 |
|
2018
Q4 | $1K | Sell |
77
-2,006
| -96% | -$26.1K | ﹤0.01% | 802 |
|
2018
Q3 | $60K | Buy |
2,083
+1,835
| +740% | +$52.9K | 0.02% | 427 |
|
2018
Q2 | $7K | Sell |
248
-2,817
| -92% | -$79.5K | ﹤0.01% | 676 |
|
2018
Q1 | $65K | Buy |
+3,065
| New | +$65K | 0.03% | 403 |
|